Related Experiment Video
Updated: Feb 21, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders
Tomohiro Watanabe1,2, Naoki Asano3, Masatoshi Kudo1
1Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine.
Nucleotide-binding oligomerization domain 1 (NOD1) senses gut bacteria, triggering immune responses. NOD1 activation is crucial for fighting infections like Helicobacter pylori but also linked to gastric diseases and pancreatitis.
Area of Science:
- Immunology
- Gastroenterology
- Microbiology
Background:
- Nucleotide-binding oligomerization domain 1 (NOD1) is an intracellular sensor recognizing bacterial peptidoglycans.
- NOD1 is expressed in epithelial and immune cells, mediating innate immunity.
- NOD1 activation influences host defense and gastrointestinal disorders.
Purpose of the Study:
- To review the molecular mechanisms of NOD1 activation.
- To explore NOD1's role in Helicobacter pylori infection and pancreatitis.
Main Methods:
- Literature review of NOD1 function in gastrointestinal diseases.
- Analysis of signaling pathways including NF-κB and type I interferon.
- Examination of NOD1's role in autophagy induction.
Main Results:
- NOD1 activation elicits innate immune responses crucial for host defense.
- NOD1-mediated responses are implicated in H. pylori-related gastric diseases.
- NOD1 signaling contributes to the pathogenesis of pancreatitis.
Conclusions:
- NOD1 plays a dual role in host defense and disease development.
- Understanding NOD1 mechanisms is key for managing H. pylori infections and pancreatitis.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
09:31Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Related Concept Videos
Gastrointestinal Motility Disorders
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...